Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02737631 · ClinicalTrials.gov registry record · NA
Human Repeat Insult Patch Test to Evaluate Personal Lubricants
A NA study of Edema and Erythema, sponsored by Church & Dwight Company.
- Completed
- Registry status
- NA
- Development phase
- 222
- Enrollment target
- 1
- Study location
NCT02737631: Completed NA study of Edema and Erythema, sponsored by Church & Dwight Company.
NCT02737631 is a NA study of Edema and Erythema that has completed, run by Church & Dwight Company. The registered enrollment target is 222 participants, below the 448-participant average among 13 other Edema trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02737631, a NA study of Edema and Erythema, has completed, sponsored by Church & Dwight Company.
- COMPLETED
- Registry status
- NA
- Development phase
- 222 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this test is to evaluate the sensitizing potential of a personal lubricant, as a result of repeated occlusive patch. The intervention will be applied for a total of 9 induction applications, followed by an approximately 2 week rest period, then followed by a 24-72 hour Challenge applications.
Interventions
- DEVICE "Chameleon" Personal Lubricant
Study Locations (1)
New Jersey
- Harrison Research Laboratories, Inc. - Union
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 222 participants |
| Start Date | 2016-02 |
| Est. Completion | 2016-03 |
| Phase | NA |
What the finished NCT02737631 record still lists
NCT02737631 is an interventional study that assigns participants to a tested intervention. The registered 222 participants enrollment target is mid-sized for trials with a published cap, below the 448-participant average among 13 other Edema trials with a reported enrollment target (50% lower).
The record links to 2 conditions, with Edema appearing as the primary indexed condition, and to 1 intervention - of which "Chameleon" Personal Lubricant is the first listed.
NCT02737631 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT02737631 about?
NCT02737631 is a clinical study titled "Human Repeat Insult Patch Test to Evaluate Personal Lubricants". The purpose of this test is to evaluate the sensitizing potential of a personal lubricant, as a result of repeated occlusive patch. The intervention will be applied for a total of 9 induction applications, followed by an approximately 2 week rest period, then followed by a 24-72 hour Challenge appli...
What is the current status of trial NCT02737631?
This trial is currently completed. It is a NA study. The enrollment target is 222 participants. The study started on 2016-02. Estimated completion is 2016-03.
What conditions does trial NCT02737631 study?
This clinical trial studies the following conditions: Edema, Erythema.
What interventions are being tested in trial NCT02737631?
The interventions under investigation include: "Chameleon" Personal Lubricant (DEVICE).
Who is sponsoring clinical trial NCT02737631?
This trial is sponsored by Church & Dwight Company, which has 19 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02737631 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Edema
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02737631's enrollment target sits among peer trials
222 2nd of 13 the highest of 13 other Edema trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Edema trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Surgical Evaluation for Upper Extremity Lymphedema (BioBridge)
RECRUITING · NA
-
LymphBridge: Surgical Evaluation for Breast Cancer-Associated Lymphedema (BioBridge)
RECRUITING · NA
-
Diuretic Tuner Clinical Decision Support
RECRUITING · NA
-
Foot and Ankle Post-operative Oedema Management Using Geko™
COMPLETED · NA
-
A Single-Center, Clinical Study to Evaluate the Safety of a Fragranced Personal Lubricant in Healthy Female Subjects
COMPLETED · NA
-
A Single-Center, Clinical Study to Evaluate the Safety of a New Personal Lubricant in Healthy Female Subjects
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04939610 · 222 participants · Phase 1
A Study of 177Lu-FAP-2286 in Advanced Solid Tumors
- NCT05424783 · 222 participants
MRI And GPS Informing Choices for Prostate Cancer Treatment (MAGIC)
- NCT05568264 · 222 participants · NA
Effects of a Physical Therapy Intervention on Motor Delay in Infants Admitted to a Neonatal Intensive Care Unit
- NCT05605574 · 222 participants · NA
Longitudinal Early Advance Care Planning Discussions and Documentation (LEADD) Program: An Exploratory Study in Adolescents and Young Adults (AYAs) Receiving Hematopoietic Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia